ClinicalTrials.gov
ClinicalTrials.gov Menu

Celect Vena Cava Filter Clinical Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00470626
Recruitment Status : Completed
First Posted : May 8, 2007
Results First Posted : April 6, 2010
Last Update Posted : January 25, 2016
Sponsor:
Collaborators:
MED Institute, Incorporated
William Cook Australia
William Cook Europe
Cook Ireland, Ltd.
Information provided by (Responsible Party):
Cook Group Incorporated

Brief Summary:
The clinical study will collect data to verify the safety and performance of the Cook Celect Filter in the prevention of pulmonary embolism (PE) in patients with a temporary or permanent high risk of thromboembolism.

Condition or disease Intervention/treatment Phase
Pulmonary Embolism Venous Thromboembolism Device: Celect Vena Cava Filter Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 129 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prospective Study of the Cook Celect Filter, Including Permanent and Retrievable Use
Study Start Date : November 2005
Actual Primary Completion Date : March 2009
Actual Study Completion Date : March 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: 1
Vena Cava Filter
Device: Celect Vena Cava Filter
Effective filtration of inferior vena cava blood to prevent thromboembolism.



Primary Outcome Measures :
  1. Major Adverse Event [ Time Frame: up to 12 months ]
    Composite Major Adverse Event includes hemorrhage, perforation, pulmonary embolism, procedure-related or device-related death, occlusion, significant migration and filter fracture.


Secondary Outcome Measures :
  1. Successful Retrieval [ Time Frame: up to 12 months ]
    Retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. A decision to remove a filter was made after determining that the patient no longer required the filter. Retrieval attempts were either successful (i.e., the filter was removed) or unsuccessful (i.e., the filter could not be removed and remained in the patient as a permanent device).

  2. Mean Time to Retrieval Attempt [ Time Frame: up to 12 months ]

    Mean time to retrieval describes the average time filters were in place in the study group before a retrieval attempt was made.

    A retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. The mean time to retrieval describes the average time filters were in place before a retrieval attempt was made.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • The patient is at high risk for pulmonary embolism and is under consideration for placement of a permanent or short-term IVC filter.
  • The patient must have a patent internal jugular vein.
  • The patient or guardian must have given informed consent.
  • The patient must agree to return for clinical imaging follow-up at 1, 3, 6, and 12 months.
  • The patient must agree to have a clinical and imaging examination performed prior to filter retrieval.
  • The patient must agree to return for clinical and imaging follow-up at 30 days and 3 months after filter retrieval.

Exclusion Criteria:

  • The patient is less than 18 years of age.
  • The patient is pregnant.
  • The patient has uncontrollable coagulopathy.
  • The patient has a life expectancy less than 6 months.
  • The patient has a vena cava diameter over 30 mm, measured by vena cava sizing catheters.
  • The patient's vena cava diameter is less than 15 mm, measured by vena cava sizing catheters.
  • The patient has a contrast allergy that can not be adequately pre-medicated.
  • The patient is simultaneously participating in another investigative drug or device study, or has a previous IVC filter.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00470626


Locations
Australia
The Alfred Hospital
Melbourne, Australia, 3181
Germany
RWTH Aachen University
Aachen, Germany, D-52057
Mexico
Instituto Nacional de Enfermedades Respiratorias
Mexico City, Mexico, 14080
Hospital Universitario de Nuevo Leon
Monterrey, Mexico, 64460
Spain
Universitario Zaragoza - Hospital Clinico
Zaragoza, Spain, 50009
United Kingdom
North Hampshire Hospital
Hampshire, United Kingdom, RG24 9NA
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom, LS97TF
John Radcliffe Hospital
Oxford, United Kingdom, OX3 9DU
Sponsors and Collaborators
Cook Group Incorporated
MED Institute, Incorporated
William Cook Australia
William Cook Europe
Cook Ireland, Ltd.
Investigators
Principal Investigator: R.W. Gunther, Prof. Klinik Fur Radiologische Diagnostik Universitaetklinikum der RWTH Aachen

Publications of Results:
Responsible Party: Cook Group Incorporated
ClinicalTrials.gov Identifier: NCT00470626     History of Changes
Other Study ID Numbers: 05-507
110006, GTMX
First Posted: May 8, 2007    Key Record Dates
Results First Posted: April 6, 2010
Last Update Posted: January 25, 2016
Last Verified: December 2015

Keywords provided by Cook Group Incorporated:
Pulmonary Embolism
Venous Thromboembolism
Inferior Vena Cava Filter
IVC
PE

Additional relevant MeSH terms:
Thromboembolism
Embolism
Venous Thromboembolism
Pulmonary Embolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases